Monomethyl auristatin F (MMAF) is a synthetic peptide analog of the natural compound dolastatin 10. MMAF is a microtubule inhibitor, disrupts the formation of microtubules. MMAF is often used in conjunction with monoclonal antibodies as part of an antibody-drug conjugate (ADC) therapy. Specifications Cat.No. 31904ES60/31904ES80 Size 100 μg/1 mg Source Monoclonal anti-MMAF antibody, is produced from a hybridoma which was obtained from a mouse immunized with MMAF. Buffer 1×PBS, pH7.4. Type Monoclonal Antibody Isotype IgG1 Host Mouse Concentration 1 mg/mL Purity >92% as determined by reduced SDS-PAGE >98% as determined by non-reduced SDS-PAGE > 91% as determined by SEC-HPLC Activity EC50=13 ng/mL by ELISA Application ELISA Notes This product is for research use only. Please operate with lab coats and disposable gloves, for your safety. Data SDS-PAGE Anti-MMAF mouse mAb on SDS-PAGE under reduced condition. The purity is 92.3%; Anti-MMAF mouse mAb on SDS-PAGE under non-reduced condition. The purity is 98.5%. SEC-HPLC The purity of Anti-MMAF mouse mAb is 91.2% as determined by SEC-HPLC. ELISA Data Dose response curve shows that the EC50 of Anti-MMAF mouse mAb is 13 ng/mL.